Financial reports
10-Q
2017 Q3
Quarterly report
14 Nov 17
10-Q
2017 Q2
Quarterly report
1 Aug 17
10-Q
2017 Q1
Quarterly report
9 May 17
10-K
2016 FY
Annual report
14 Mar 17
10-Q
2016 Q3
Quarterly report
2 Nov 16
10-Q
2016 Q2
Quarterly report
4 Aug 16
10-Q
2016 Q1
Quarterly report
3 May 16
10-K
2015 FY
Annual report
11 Mar 16
10-Q
2015 Q3
Quarterly report
5 Nov 15
10-Q
2015 Q2
Quarterly report
10 Aug 15
Current reports
8-K
Termination of a Material Definitive Agreement
11 Dec 17
8-K
Tender and Support Agreement
2 Nov 17
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Sep 17
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 Aug 17
8-K
Ocera Therapeutics Reports Second Quarter 2017 Financial Results
1 Aug 17
8-K
Submission of Matters to a Vote of Security Holders
22 Jun 17
8-K
Ocera Therapeutics Reports First Quarter 2017 Financial Results and Provides Clinical Update
9 May 17
8-K
Departure of Directors or Certain Officers
31 Mar 17
8-K
Ocera Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
10 Mar 17
8-K
Regulation FD Disclosure
8 Mar 17
Registration and prospectus
15-12B
Securities registration termination
21 Dec 17
25-NSE
Exchange delisting
11 Dec 17
POS AM
Prospectus update (post-effective amendment)
11 Dec 17
POS AM
Prospectus update (post-effective amendment)
11 Dec 17
POS AM
Prospectus update (post-effective amendment)
11 Dec 17
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Dec 17
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Dec 17
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Dec 17
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Dec 17
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Dec 17
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 17
DEF 14A
Definitive proxy
25 Apr 17
DEF 14A
Definitive proxy
22 Apr 16
DEFA14A
Additional proxy soliciting materials
22 Apr 16
DEF 14A
Definitive proxy
24 Apr 15
DEFA14A
Additional proxy soliciting materials
24 Apr 15
DEF 14A
Definitive proxy
29 Apr 14
DEF 14A
Definitive proxy
15 Nov 13
DEFA14A
Additional proxy soliciting materials
10 Jul 13
DEFA14A
Additional proxy soliciting materials
24 Jun 13
Other
EFFECT
Notice of effectiveness
13 Dec 17
EFFECT
Notice of effectiveness
13 Dec 17
EFFECT
Notice of effectiveness
13 Dec 17
UPLOAD
Letter from SEC
14 Nov 17
CT ORDER
Confidential treatment order
18 Mar 16
EFFECT
Notice of effectiveness
28 May 15
UPLOAD
Letter from SEC
21 Oct 14
CORRESP
Correspondence with SEC
3 Oct 14
UPLOAD
Letter from SEC
25 Sep 14
CT ORDER
Confidential treatment order
19 Jun 14
Ownership
SC 13G/A
Ocera Therapeutics, Inc.
14 Feb 18
SC 13G/A
Ocera Therapeutics, Inc.
14 Feb 18
SC 13D/A
Ocera Therapeutics, Inc.
21 Dec 17
SC 13D/A
Ocera Therapeutics, Inc.
14 Dec 17
4
Brian K Halak
13 Dec 17
4
Brian K Halak
13 Dec 17
4
BRIAN H DOVEY
13 Dec 17
4
BRIAN H DOVEY
13 Dec 17
4
Brian K Halak
13 Dec 17
4
Willard H Dere
11 Dec 17